 Psilocybin-focused mental health care company COMPASS Pathways plc NASDAQ:CMPS revealed Friday that it has been selected for addition to the Nasdaq Biotechnology Index NASDAQ:NBI, effective as of market open on Monday, Dec. 20. We are proud to announce our addition to the esteemed Nasdaq Biotechnology Index, George Goldsmith, CEO and founder of Compass Pathways said. 